329 related articles for article (PubMed ID: 29293660)
1. Memory CD8 T cells mediate severe immunopathology following respiratory syncytial virus infection.
Schmidt ME; Knudson CJ; Hartwig SM; Pewe LL; Meyerholz DK; Langlois RA; Harty JT; Varga SM
PLoS Pathog; 2018 Jan; 14(1):e1006810. PubMed ID: 29293660
[TBL] [Abstract][Full Text] [Related]
2. Pre-existing neutralizing antibodies prevent CD8 T cell-mediated immunopathology following respiratory syncytial virus infection.
Schmidt ME; Meyerholz DK; Varga SM
Mucosal Immunol; 2020 May; 13(3):507-517. PubMed ID: 31844172
[TBL] [Abstract][Full Text] [Related]
3. Tissue-Resident Memory T Cells in the Lungs Protect against Acute Respiratory Syncytial Virus Infection.
Luangrath MA; Schmidt ME; Hartwig SM; Varga SM
Immunohorizons; 2021 Feb; 5(2):59-69. PubMed ID: 33536235
[TBL] [Abstract][Full Text] [Related]
4. Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenza-specific resident memory T-cell responses.
Matyushenko V; Kotomina T; Kudryavtsev I; Mezhenskaya D; Prokopenko P; Matushkina A; Sivak K; Muzhikyan A; Rudenko L; Isakova-Sivak I
Antiviral Res; 2020 Oct; 182():104864. PubMed ID: 32585323
[TBL] [Abstract][Full Text] [Related]
5. CD8 T cells inhibit respiratory syncytial virus (RSV) vaccine-enhanced disease.
Olson MR; Varga SM
J Immunol; 2007 Oct; 179(8):5415-24. PubMed ID: 17911628
[TBL] [Abstract][Full Text] [Related]
6. Improved effector activity and memory CD8 T cell development by IL-2 expression during experimental respiratory syncytial virus infection.
Chang J; Choi SY; Jin HT; Sung YC; Braciale TJ
J Immunol; 2004 Jan; 172(1):503-8. PubMed ID: 14688360
[TBL] [Abstract][Full Text] [Related]
7. Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection.
Srikiatkhachorn A; Braciale TJ
J Exp Med; 1997 Aug; 186(3):421-32. PubMed ID: 9236194
[TBL] [Abstract][Full Text] [Related]
8. STAT4 deficiency fails to induce lung Th2 or Th17 immunity following primary or secondary respiratory syncytial virus (RSV) challenge but enhances the lung RSV-specific CD8+ T cell immune response to secondary challenge.
Dulek DE; Newcomb DC; Toki S; Goliniewska K; Cephus J; Reiss S; Bates JT; Crowe JE; Boyd KL; Moore ML; Zhou W; Peebles RS
J Virol; 2014 Sep; 88(17):9655-72. PubMed ID: 24920804
[TBL] [Abstract][Full Text] [Related]
9. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM
J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098
[TBL] [Abstract][Full Text] [Related]
10. Gene-gun DNA vaccination aggravates respiratory syncytial virus-induced pneumonitis.
Bartholdy C; Olszewska W; Stryhn A; Thomsen AR; Openshaw PJM
J Gen Virol; 2004 Oct; 85(Pt 10):3017-3026. PubMed ID: 15448365
[TBL] [Abstract][Full Text] [Related]
11. Efficient lung recruitment of respiratory syncytial virus-specific Th1 cells induced by recombinant bacillus Calmette-Guérin promotes virus clearance and protects from infection.
Cautivo KM; Bueno SM; Cortes CM; Wozniak A; Riedel CA; Kalergis AM
J Immunol; 2010 Dec; 185(12):7633-45. PubMed ID: 21084664
[TBL] [Abstract][Full Text] [Related]
12. Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection.
Fulton RB; Meyerholz DK; Varga SM
J Immunol; 2010 Aug; 185(4):2382-92. PubMed ID: 20639494
[TBL] [Abstract][Full Text] [Related]
13. Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice.
De Baets S; Schepens B; Sedeyn K; Schotsaert M; Roose K; Bogaert P; Fiers W; Saelens X
J Virol; 2013 Mar; 87(6):3314-23. PubMed ID: 23302879
[TBL] [Abstract][Full Text] [Related]
14. Aged mice exhibit a severely diminished CD8 T cell response following respiratory syncytial virus infection.
Fulton RB; Weiss KA; Pewe LL; Harty JT; Varga SM
J Virol; 2013 Dec; 87(23):12694-700. PubMed ID: 24049171
[TBL] [Abstract][Full Text] [Related]
15. Respiratory syncytial virus elicits enriched CD8+ T lymphocyte responses in lung compared with blood in African green monkeys.
Li H; Callahan C; Citron M; Wen Z; Touch S; Monslow MA; Cox KS; DiStefano DJ; Vora KA; Bett A; Espeseth A
PLoS One; 2017; 12(11):e0187642. PubMed ID: 29121080
[TBL] [Abstract][Full Text] [Related]
16. Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus.
Bukreyev A; Belyakov IM; Prince GA; Yim KC; Harris KK; Berzofsky JA; Collins PL
J Virol; 2005 Aug; 79(15):9515-26. PubMed ID: 16014914
[TBL] [Abstract][Full Text] [Related]
17. Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector.
Martinez-Sobrido L; Gitiban N; Fernandez-Sesma A; Cros J; Mertz SE; Jewell NA; Hammond S; Flano E; Durbin RK; García-Sastre A; Durbin JE
J Virol; 2006 Feb; 80(3):1130-9. PubMed ID: 16414990
[TBL] [Abstract][Full Text] [Related]
18. Differential role of gamma interferon in inhibiting pulmonary eosinophilia and exacerbating systemic disease in fusion protein-immunized mice undergoing challenge infection with respiratory syncytial virus.
Castilow EM; Olson MR; Meyerholz DK; Varga SM
J Virol; 2008 Mar; 82(5):2196-207. PubMed ID: 18094193
[TBL] [Abstract][Full Text] [Related]
19. Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats.
Widjojoatmodjo MN; Bogaert L; Meek B; Zahn R; Vellinga J; Custers J; Serroyen J; Radošević K; Schuitemaker H
Vaccine; 2015 Oct; 33(41):5406-5414. PubMed ID: 26319741
[TBL] [Abstract][Full Text] [Related]
20. A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models.
Lambert SL; Aslam S; Stillman E; MacPhail M; Nelson C; Ro B; Sweetwood R; Lei YM; Woo JC; Tang RS
PLoS One; 2015; 10(3):e0119509. PubMed ID: 25793508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
